NCT05220033Active, not recruiting
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 22 Nov 2021
- Start date
- 14 Jul 2020
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Rutgers, The State University of New Jersey
- Diseases
- Endometrial cancer, Cervical cancer, Ovarian cancer
- NCT number
- NCT05220033
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 14 Jul 2020 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Diagnosed with any stage of primary ovarian cancer, primary peritoneal cancer, or primary fallopian tube cancer or experienced a recurrence in the past 5 years;
- Diagnosed with High Grade Stage 2, any grade Stage 3 or higher endometrial cancer or experienced a recurrence in the past 5 years;
- Diagnosed with Stage 2 or higher cervical cancer or experienced a recurrence within the past 5 years;
- Diagnosed with any stage Uterine Cancer (both Sarcoma and carcinosarcoma) or experienced a recurrence in the past 5 years;
- At the time of recruitment the patient has received chemotherapy or radiation in the past 5 years, or is less than 5 years post-cancer surgery;
- At the time of recruitment, a Karnofsky Performance Status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) (80) score of 0 or 1;
- 18 years of age or older;
- English speaking;
- Has internet access, able to view the online intervention sessions and attend telephone or video/telehealth chats to discuss the session content and provide feedback;
- Must give informed consent within 5 years of diagnosis.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rutgers Cancer Institute of New Jersey Coordinator of this site? Confirm its status | New Brunswick | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.